Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Oxford Researchers Aim To Improve Diagnosis of Pneumonia In Children

XTALKS VITALS NEWS

Pediatrics

Specialized equipment like X-ray machines are currently required for doctors to properly diagnose pneumonia and assess how serious it is in a pediatric patient.

Tweetables from this article:

Tweet: 99 percent of all pneumonia-related deaths in children occur in developing nations http://ctt.ec/AXdWd+99 percent of all pneumonia-related deaths in children occur in developing nations.

Tweet: Pediatric death rates can be reduced by 42% if health workers have the tools to accurately diagnose pneumonia http://ctt.ec/b3T35+Pediatric death rates can be reduced by 42 percent if health workers have the tools to accurately diagnose pneumonia.

Share this!

August 4, 2016 | by Sarah Massey, M.Sc.

Pneumonia is the top killer of children under five, worldwide. To improve diagnosis of the potentially life-threatening illness, researchers at Oxford University are developing a less-expensive and easier diagnostic tool for clinicians.

Specialized equipment like X-ray machines are currently required for doctors to properly diagnose pneumonia and assess how serious it is in a pediatric patient. However, 99 percent of all pneumonia-related deaths in children occur in developing nations, and health workers there do not always have access to the proper diagnostic equipment.

“With the nearest hospital hours away, generalist health workers depend on a set of guidelines known as IMCI [Integrated Management of Childhood Illness],” said Elina Naydenova, of Oxford University’s Institute for Biomedical Engineering. “These can sometimes be good at identifying cases of pneumonia but not so good at screening out cases that are not pneumonia.

“There is also huge variability across users. In settings, where there isn’t a clinical expert to set a conclusive diagnosis, the number of unnecessary antibiotic prescriptions has increased as a result – depleting vital drug supplies and adding to the problem of antibiotic-resistant infections,” Naydenova continued. “We wanted to apply smart engineering to develop a robust automated system that was consistently more accurate.”



Pediatric death rates can be reduced by 42 percent if health workers have the tools necessary to accurately diagnose pneumonia and determine the severity of the infection. Based on the diagnosis, decisions must be made on whether the child should be admitted to hospital and whether antibiotics should be given if the infection is bacterial. All of these choices have a major impact on clinical outcomes for the patient, and health workers only have a few basic, portable pieces of equipment with which to make these decisions.

To develop an automated diagnostic tool, the Oxford researchers analyzed data collected from a clinical study conducted in Gambia. Using machine learning techniques, Naydenova and her colleagues worked towards developing an algorithm capable of helping health workers diagnose pneumonia.

“For identifying pneumonia we found four features that can be measured with two pieces of equipment. Heart rate, respiratory rate and oxygen saturation can all be measured using a pulse oximeter,” said Naydenova. “Temperature requires a thermometer. These are things that can be made available to a health worker with basic training.

“Using these four measures, we achieved 98.2% sensitivity and 97.5% specificity, compared to IMCI, where the best performance is 94% sensitivity and 69% specificity,” she continued. These results indicate that the Oxford tool could identify 982 in every 1000 pneumonia cases, and only generate a false-positive result in 2.5 percent of cases.

“We have identified a set of features that could offer an alternative to the combination of X-rays and blood cultures only available in a well-equipped hospital,” said Naydenova. “These will be used in a mobile application linked to a set low-cost diagnostic equipment, which we will be trialing in the next couple of years.”


Keywords: Pneumonia, Pediatrics, Diagnostic Tool


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Exclusion Criteria for Clinical Trials Poses Major Barrier to Patient Enrollment

August 17, 2017 - UT Southwestern researchers say that clinical investigators continue to increase the number of exclusion criteria, preventing more patients from participating in clinical trials.

Featured In: Clinical Trials News


Targeting Cellular Nitrogen Metabolism Could Offer a New Treatment for Pancreatic Cancer

August 17, 2017 - An enzyme involved in regulating the amount of nitrogen in the cell could be a new drug target for pancreatic cancer, according to researchers from Boston Children's Hospital and the Broad Institute of MIT and Harvard.

Featured In: Life Science News


Regeneron’s Drug for Respiratory Syncytial Virus Fails in Phase III Clinical Trial

August 16, 2017 - Biotechnology company Regeneron has announced it will not continue development of its antibody drug, suptavumab, after a failure in a Phase III clinical trial.

Featured In: Clinical Trials News


LEAVE A COMMENT
 
  
THE XTALKS VITALS INDUSTRY BLOG

One Patient’s Perspective on Clinical Trials

REGISTER FOR THESE WEBINARS

Planning and Conducting Trials of the Latest Immunotherapies


ISO 13485:2016 for Medical Device Manufacturers: Ensuring a Smooth Transition through Effective Preparation


Medical Devices: Reviewing Regulatory Changes in the US and EU


Moving Beyond Regulatory and Performance Metrics in Starting Clinical Trials


Copyright © 2016-2017 Honeycomb Worldwide Inc.